Diabetes mellitus in coronary bypass surgery: Risks and chances. Treatment concepts for a particularly challenging group of patients;Diabetes mellitus in der koronarchirurgie: Risiken und chancen. Behandlungskonzepte für eine besonders herausfordernde patientengruppe

Herz

Volumn 33, Issue 3, 2008, Pages 212-221

  Lauruschkat, Achim Helmut ^a   Ennker, Jürgen ^a  

^a Herzzentrum Lahr/Baden   (Germany)

Author keywords

Blood glucose; Coronary artery bypass graft surgery; Diabetes mellitus; Metabolism; Percutaneous coronary intervention; Risk factors

Indexed keywords

CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; INSULIN TREATMENT; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; REVIEW; SURGICAL TECHNIQUE; WOUND INFECTION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; INSULIN; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 42549123358     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-008-3114-4     Document Type: Review

References (90)

1. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. Circulation 1995;91:2335-44.
2. Weintraub WS, Ghazzal ZM, Douglas JS Jr, et al. Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty. Circulation 1993;87:831-40.
3. Flaherty JD, Davidson CJ. Diabetes and coronary revascularization. JAMA 2005;293:1501-8.
4. Filsoufi F, Rahmanian PB, Castillo JG, et al. Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2007;6:753-8.
5. Lauruschkat AH, Arnrich B, Albert AA, et al. Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. Circulation 2005;112:2397-402.
6. Hauner H. Verbreitung des Diabetes mellitus in Deutschland. Dtsch Med Wochenschr 1998;123:777-82.
7. Hauner H, Köster I, Schubert I. Prevalence of diabetes mellitus and quality of care in Hessen, Germany, 1998-2004. Dtsch Ärztebl 2007;104:2799-805.
8. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993;16:642-52.
9. Rathmann W, Haastert B, Icks A, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003;46:182-9.
10. Hauner H. Diabetesepidemie und Dunkelziffer. Mainz: Kirchheim, 2008.
11. Gao G, Wu Y, Grunkemeier GL, et al. Long-term survival of patients after coronary artery bypass graft surgery: comparison of the pre-stent and post-stent eras. Ann Thorac Surg 2006;82:806-10.
12. Protocoll for the Bypass Angioplasty Revascularization Investigation. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Circulation 1991;84:Suppl V:V1-27.
13. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation. Circulation 1997;96:1761-9.
14. Brooks MM, Jones RH, Bach RG, et al, for the BARI Investigators. Predictors of mortality and mortality from cardiac causes in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and registry. Circulation 2000;101:2682-9.
15. Niles NW, McGrath PD, Malenka D, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 2001;37:1016-8.
16. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007;49:1600-6.
17. Abizaid A, Costa MA, Centemero M, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients. Insights from the Arterial Revascularization Therapy Study (ARTS) Trial. Circulation 2001;104:533-8.
18. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-24.
19. Brener SJ, Lytle BW, Casserly IP, et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 2004;109:2290-5.
20. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005;352:2174-83.
21. Smith PK, Califf RM, Tuttle RH, et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg 2006;82:1420-8, discussion 1428-9.
22. Van Domburg RT, Takkenberg JJ, Noordzij LJ, et al. Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study. Ann Thorac Surg 2005;79:1563-9.
23. Holmes DR, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a siro limus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004;109:634-40.
24. Dibra A, Kastrati A, Mehilli J, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-70.
25. Babapulle MN, Joseph L, Belisle P, et al. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004;364:583-91.
26. Hill RA, Dundar Y, Bakhai A, et al. Drug-eluting stents: an early systematic review to inform policy. Eur Heart J 2004;25:902-19.
27. Guyton RA. Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease. Ann Thorac Surg 2006;81:1949-57.
28. Katritsis DG, Karvouni E, Ioannidis JP. Meta-analysis comparing drug-eluting stents with bare metal stents. Am J Cardiol 2005;95:640-3.
29. Lemos P, Serruys P, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare metal stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry. Circulation 2004;109:190-5.
30. Iijima R, Ndrepepa G, Mehilli J, et al. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J 2007;154:688-93.
31. Herz I, Moshkovitz Y, Loberman D, et al. Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease. Ann Thorac Surg 2005;80:2086-90.
32. Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007;116:Suppl:I200-6.
33. Gum PA, O'Keefe JH Jr, Borkon AM, et al. Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients. Circulation 1997;96:Suppl:II-7-10.
34. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1996;335:217-25.
35. Abizaid A, Kornowski R, Mintz G, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-9.
36. Rozenman Y, Sapoznikov D, Mosseri M, et al. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. J Am Coll Cardiol 1997;30:1420-5.
37. Cutlip DE, Chhabra AG, Baim DS, et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation 2004;110:1226-30.
38. Klein LW. Are drug-eluting stents the preferred treatment for multivessel coronary artery disease? J Am Coll Cardiol 2006;47:22-6.
39. Greenberg D, Bakhai A, Neil N, et al. Modeling the impact of patient and lesion characteristics on the cost-effectiveness of drug-eluting stents. J Am Coll Cardiol 2003;41:Suppl A:538A.
40. Kuntz RE. Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma. Circulation 1999;99:847-51.
41. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004;110:e340-437.
42. Thielmann M, Neuhauser M, Knipp S, et al. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007;134:470-6.
43. Detre KM, Lombardero MS, Brooks MM, et al. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med 2000;342:989-97.
44. Rankin JS, Harrell FE Jr. Measuring the therapeutic efficacy of coronary revascularization: implications for future management. J Thorac Cardiovasc Surg 2006;131:944-8.
45. Stevens LM, Carrier M, Perrault LP, et al. Influence of diabetes and bilateral internal thoracic artery grafts on long-term outcome for multivessel coronary artery bypass grafting. Eur J Cardiothorac Surg 2005;27:281-8.
46. Lev-Ran O, Braunstein R, Nesher N, et al. Bilateral versus single internal thoracic artery grafting in oral-treated diabetic subsets: comparative seven-year outcome analysis. Ann Thorac Surg 2004;77:2039-45.
47. Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-26.
48. Ruengsakulrach P, Sinclair R, Komeda M, et al. Comparative histopathology of radial artery versus internal thoracic artery and risk factors for development of intimal hyperplasia and atherosclerosis. Circulation 1999;100:Suppl:II139-44.
49. Wendler O, Landwehr P, Bandner-Risch D, et al. Vasoreactivity of arterial grafts in the patient with diabetes mellitus: investigations on internal thoracic artery and radial artery conduits. Eur J Cardiothorac Surg 2001;20:305-11.
50. Taggart DP, D'Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet 2001;358:870-5.
51. Possati G, Gaudino M, Prati F, et al. Long-term results of the radial artery used for myocardial revascularization. Circulation 2003;108:1350-4.
52. Borger MA, Rao V, Weisel RD, et al. Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg 1998;65:1050-6.
53. Grossi EA, Esposito R, Harris LJ, et al. Sternal wound infections and use of internal mammary artery grafts. J Thorac Cardiovasc Surg 1991;102:342-6, discussion 346-7.
54. He GW, Ryan WH, Acuff TE, et al. Risk factors for operative mortality and sternal wound infection in bilateral internal mammary artery grafting. J Thorac Cardiovasc Surg 1994;107:196-202.
55. Gansera B, Schmidtler F, Gillrath G, et al. Does bilateral ITA grafting increase perioperative complications? Outcome of 4462 patients with bilateral versus 4204 patients with single ITA bypass. Eur J Cardiothorac Surg 2006;30:318-23.
56. Maniar HS, Sundt TM, Barner HB, et al. Effect of target stenosis and location on radial artery graft patency. J Thorac Cardiovasc Surg 2002;123:45-53.
57. Choudhary BP, Antoniades C, Brading AF, et al. Diabetes mellitus as a predictor for radial artery vasoreactivity in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2007;50:1047-53.
58. Nicolosi AC, Pohl LL, Parsons P, et al. Increased incidence of radial artery calcification in patients with diabetes mellitus. J Surg Res 2002;102:1-5.
59. Lytle BW, Blackstone EH, Sabik JF, et al. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 2004;78:2005-12, discussion 2012-4.
60. Rizzoli G, Schiavon L, Bellini P. Does the use of bilateral internal mammary artery (IMA) grafts provide incremental benefit relative to the use of a single IMA graft? A meta-analysis approach. Eur J Cardiothorac Surg 2002;22:781-6.
61. De Paulis R, de Notaris S, Scaffa R, et al. The effect of bilateral internal thoracic artery harvesting on superficial and deep sternal infection: the role of skeletonization. J Thorac Cardiovasc Surg 2005;129:536-43.
62. Loop FD, Lytle BW, Cosgrove DM, et al. J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 1990;49:179-86, discussion 186-7.
63. Momin AU, Deshpande R, Potts J, et al. Incidence of sternal infection in diabetic patients undergoing bilateral internal thoracic artery grafting. Ann Thorac Surg 2005;80:1765-72, discussion 1772.
64. Matsa M, Paz Y, Gurevitch J, et al. Bilateral skeletonized internal thoracic artery grafts in patients with diabetes mellitus. J Thorac Cardiovasc Surg 2001;121:668-74.
65. Lev-Ran O, Mohr R, Pevni D, et al. Bilateral internal thoracic artery grafting in diabetic patients: short-term and long-term results of a 515-patient series. J Thorac Cardiovasc Surg 2004;127:1145-50.
66. Lorberboym M, Medalion B, Bder O, et al. 99mTc-MDP bone SPECT for the evaluation of sternal ischaemia following internal mammary artery dissection. Nucl Med Commun 2002;23:47-52.
67. Hirose H, Amano A, Takanashi S, et al. Skeletonized bilateral internal mammary artery grafting for patients with diabetes. Interact Cardiovasc Thorac Surg 2003;2:287-92.
68. Bical OM, Khoury W, Fromes Y, et al. Routine use of bilateral skeletonized internal thoracic artery grafts in middle-aged diabetic patients. Ann Thorac Surg 2004;78:2050-3.
69. Peterson MD, Borger MA, Rao V, et al. Skeletonization of bilateral internal thoracic artery grafts lowers the risk of sternal infection in patients with diabetes. J Thorac Cardiovasc Surg 2003;126:1314-9.
70. Choi JB, Lee SY. Skeletonized and pedicled internal thoracic artery grafts: effect on free flow during bypass. Ann Thorac Surg 1996;61:909-13.
71. Wendler O, Tscholl D, Huang Q, et al. Free flow capacity of skeletonized versus pedicled internal thoracic artery grafts in coronary artery bypass grafts. Eur J Cardiothorac Surg 1999;15:247-50.
72. Sabik JF 3rd, Lytle BW, Blackstone EH, et al. Comparison of saphenous vein and internal thoracic artery graft patency by coronary system. Ann Thorac Surg 2005;79:544-51.
73. Lev-Ran O, Paz Y, Pevni D, et al. Bilateral interna thoracic artery grafting: mid-term results of composite versus in-situ crossover graft. Ann Thorac Surg 2002;74:704-11, discussion 710-1.
74. Calafiore AM, Contini M, Vitolla G, et al. Bilateral internal thoracic artery grafting: long-term clinical and angiographic results of in situ versus y grafts. J Thorac Cardiovasc Surg 2000;120:990-6.
75. Albert A, Beller C, Arnrich B, et al. Is there any impact of the type of aortic end-hole cannula on stroke occurence? Clinical evaluation of straight and bent-tip aortic cannulae. Perfusion 2002;17:451-6.
76. Srinivasan AK, Grayson AD, Fabri BM. On-pump versus off-pump coronary artery bypass grafting in diabetic patients: a propensity score analysis. Ann Thorac Surg 2004;78:1604-9.
77. Weerasinghe A, Athanasiou T, Al-Ruzzeh S, et al. Functional renal outcome in on-pump and off-pump coronary revascularization: a propensity-based analysis. Ann Thorac Surg 2005;79:1577-83.
78. Abraham R, Karamanoukian HL, Jajkowski R, et al. Does avoidance of cardiopulmonary bypass decrease the incidence of stroke in diabetics undergoing coronary surgery? Heart Surg Forum 2001;4:135-40.
79. Sajja LR, Mannam G, Chakravarthi RM, et al. Coronary artery bypass grafting with or without cardiopulmonary bypass in patients with preoperative non-dialysis dependent renal insufficiency: a randomized study. J Thorac Cardiovasc Surg 2007;133:378-88.
80. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997;63:356-61.
81. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1007-21.
82. Malmberg K, Ryden L, Hamsten A, et al. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J 1996;17:1337-44.
83. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.
84. Hermans G, Wilmer A, Meersseman W, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007;175:480-9.
85. Sidenius P. The axonopathy of diabetic neuropathy. Diabetes 1982;31:356-63.
86. Taegtmeyer H, McNulty P, Young ME, Adaptation and maladaptation of the heart in diabetes. Part I: General concepts. Circulation 2002;105:1727-33.
87. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994;343:155-8.
88. Ferranini E, Santoro D, Bonadonna R, et al. Metabolic and hemodynamic effects of insulin on human hearts. Am J Physiol 1993;264:E308-15.
89. Lazar HL, Zhang X, Rivers S, et al. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions. Ann Thorac Surg 1995;60:411-6.
90. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004;109:1497-502.